MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Association analysis of SNP rs11868035 in SREBF1 with Parkinson’s disease, amyotrophic lateral sclerosis and multiple system atrophy in a Chinese population

    X. Yuan, Y. Chen, B. Cao, Q. Wei, R. Ou, H. Shang (Chengdu, People's Republic of China)

    Objective: To examine the possible genetic association of rs11868035 with Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA) in a Chinese…
  • 2016 International Congress

    Frequency of echogenic abnormality of the substantia nigra is increased in methamphetamine users

    J.J. Rumpf, J. Albers, C. Fricke, D. Weise, J. Classen (Leipzig, Germany)

    Objective: To investigate structural abnormality of the substantia nigra (SN) in methamphetamine users using transcranial sonography (TCS). Background: Epidemiologic studies suggest that chronic use of…
  • 2016 International Congress

    Pan American multiple system atrophy (PANMSA) consortium database

    M. Cesarini, A. Sanguinetti, J. Etcheverry, E. Mosto, I. Litvan, E.M. Gatto (Buenos Aires, Argentina)

    Objective: To create a database coordinating individual MSA study groups of the Pan American region with the required standards by the Global MSA Registry, as…
  • 2016 International Congress

    Impact of comorbidities and compliance initiatives in management of patients with early Parkinson’s disease

    A.V. Shalaeva, N.A. Dadabaeva, R.M. Allanov, M.B. Bozorboev, E. Shalaeva (Tashkent, Uzbekistan)

    Objective: To evaluate the impact of comorbidities and compliance iniciatives on treatment efficacy in patients with Parkinson's disease. Methods: In the year 2014 we included…
  • 2016 International Congress

    Generation and characterization of iPSC-derived nigral dopaminergic and pyramidal glutamatergic neurons from patients affected by multiple system atrophy

    G. Monzio Compagnoni, E. Frattini, S. Salani, F. Fortunato, N. Bresolin, S. Corti, G.P. Comi, A. Di Fonzo (Milan, Italy)

    Objective: The aim of the present study is to generate dopaminergic and pyramidal neurons from iPSCs of MSA patients in order to establish an in…
  • 2016 International Congress

    Triple stimulation technique findings in patients with Parkinson’s disease and multiple system atrophy

    H. Wang, Q. Ding, J. Yuan, L. Cui (Beijing, People's Republic of China)

    Objective: This study aims to evaluate the cortico-spinal tract impairment in PD and multiple system atrophy (MSA) Parkinsonian variant using triple stimulation technique (TST). Background:…
  • 2016 International Congress

    Multiple system atrophy: A comparison between clinical subtypes

    L.B. Barcelos, R.A. Saba, S.M.A. Silva, V. Borges, H.B. Ferraz (Sao Paulo, Brazil)

    Objective: To evaluate the cognitive impairment and sleep disturbances in subtype MSA-P versus MSA-C. Background: Multiple system atrophy (MSA) is a progressive neurodegenerative disorder of…
  • 2016 International Congress

    Non-motor symptoms in a PPMI cohort of p.A53T α-synuclein mutation-related and sporadic Parkinson’s disease patients

    C. Koros, M. Stamelou, I. Beratis, N. Papagiannakis, A.M. Simitsi, D. Papadimitriou, S. Fragiadaki, D. Kontaxopoulou, S.G. Papageorgiou, L. Stefanis (Athens, Greece)

    Objective: To evaluate the prevalence of non-motor symptoms in p.A53T α-synuclein (SNCA) related Parkinson's disease (PD) as compared to sporadic Parkinson's disease (sPD) patients. Background:…
  • 2016 International Congress

    Increased monosaccharide intake in patients with Parkinson’s disease

    E. Schaeffer, A. Schermann, F. Zirbs, D. Berg (Tübingen, Germany)

    Objective: To verify the clinical observation that patients with Parkinson's disease (PD) have a higher consumption of monosaccharides. Background: Patients with PD frequently report an…
  • 2016 International Congress

    Unusual motor and non-motor symptoms and signs in the early stage of Parkinson´s disease

    H.A.G. Teive, D.C. Bertucci, R.P. Munhoz (Curitiba, Brazil)

    Objective: To present unusual motor and non-motor symptoms and signs in the early stage of Parkinson´s disease. Background: Patients with Parkinson´s disease (PD) may present…
  • « Previous Page
  • 1
  • …
  • 81
  • 82
  • 83
  • 84
  • 85
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
    • Effect of marijuana on Essential Tremor: A case report
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley